MedTrace Logo

Scientific Research Barriers by Gender and Other Characteristics in Physiatry

NCT05820022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 254

Last updated 2023-07-10

No results posted yet for this study

Summary

The ever-increasing population and life expectancy worldwide lead to a higher prevalence of physical disabilities and diseases, which increases the need for physical medicine and rehabilitation research. In our study, we aimed to evaluate various aspects of the barriers, particularly gender disparities, faced by physical medicine and rehabilitation professionals who wish to conduct scientific research.

Conditions

  • Gender Bias
  • Researcher-Subject Relations

Interventions

OTHER

Research Barriers Scale

This scale was prepared after a detailed literature review and sent to five physiatrists for review and feedback. It consists of 21 items with Likert-type responses and two open-ended questions. It is designed to measure the barriers that individuals or groups face in conducting research. The scale includes a list of potential barriers and asks respondents to rate the extent to which they experience each barrier. Examples of barriers that may be included in such a scale could include lack of funding, limited access to resources or equipment, time constraints, difficulty finding participants or accessing data, institutional or administrative hurdles, and so on.

Sponsors & Collaborators

  • Uskudar State Hospital

    lead OTHER_GOV

Principal Investigators

  • Mustafa H Temel, M.D. · Uskudar State Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-06-15
Completion
2023-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820022 on ClinicalTrials.gov